Requalification as a strategic opportunity for sustainable pharmaceutical packaging

Published: 12-Dec-2025

Requalification is often viewed as a critical — albeit inconvenient — disruption in pharmaceutical operations, which is essential to ensure product quality, consistency and safety

You need to be a subscriber to read this article.
Click here to find out more.

But beyond its compliance function, this planned downtime presents a strategic opportunity to rethink packaging processes and implement innovative solutions that enhance sustainability and efficiency, explains Ian Chapman (pictured), Strategic Manager, Digital Coding, at Domino Printing Sciences. 

Sustainable packaging imperative

Pharmaceutical companies are facing mounting environmental pressure. According to American Pharmaceutical Review, it's estimated that pharmaceutical manufacturing contributes roughly 52 million tonnes of CO₂ annually via packaging and operations.

The implications are not only regulatory and financial; consumer and investor scrutiny is also driving change.

Consumers are increasingly assessing companies’ environmental performance and approximately 70% are willing to pay more for sustainable packaging options. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like